Effects of Repeated Intravitreal Injections of Dexamethasone Implants on Intraocular Pressure: A 4-Year Study.
Pacella ElenaLorenzo LoffredoMariaelena MalvasiEdoardo Trovato BattagliolaDaniela MessineoFernanda PacellaLoredana ArricoPublished in: Clinical ophthalmology (Auckland, N.Z.) (2020)
Ocular hypertension is a recognized side effect of intravitreal dexamethasone. Some patients develop it right after the first injection, while others develop it subsequently, on the 2nd or 3rd round. This side effect becomes most apparent 30-90 days following the implantation procedure and responds well to topical pressure-lowering medications.
Keyphrases
- end stage renal disease
- vascular endothelial growth factor
- low dose
- ejection fraction
- newly diagnosed
- high dose
- chronic kidney disease
- blood pressure
- diabetic retinopathy
- prognostic factors
- ultrasound guided
- age related macular degeneration
- peritoneal dialysis
- computed tomography
- magnetic resonance imaging
- minimally invasive
- magnetic resonance
- patient reported
- platelet rich plasma